GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 97 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2016. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,854,000 | +31.2% | 91,715 | +1.7% | 0.00% | 0.0% |
| Q4 2018 | $3,701,000 | -48.2% | 90,152 | -52.0% | 0.00% | +50.0% |
| Q3 2018 | $7,140,000 | +54.2% | 187,904 | +83.4% | 0.00% | -33.3% |
| Q2 2018 | $4,630,000 | +3.2% | 102,429 | +10.3% | 0.00% | 0.0% |
| Q1 2018 | $4,485,000 | +26.5% | 92,862 | +3.1% | 0.00% | +50.0% |
| Q4 2017 | $3,546,000 | -9.4% | 90,111 | -28.5% | 0.00% | -33.3% |
| Q3 2017 | $3,915,000 | -43.9% | 126,073 | -50.6% | 0.00% | -40.0% |
| Q2 2017 | $6,975,000 | +44.9% | 255,045 | +95.3% | 0.01% | +66.7% |
| Q1 2017 | $4,813,000 | +258.4% | 130,606 | +40.5% | 0.00% | +200.0% |
| Q4 2016 | $1,343,000 | -7.0% | 92,934 | +48.3% | 0.00% | 0.0% |
| Q3 2016 | $1,444,000 | +94.3% | 62,651 | +40.0% | 0.00% | 0.0% |
| Q2 2016 | $743,000 | +112.9% | 44,761 | +103.3% | 0.00% | – |
| Q1 2016 | $349,000 | -65.6% | 22,013 | -29.9% | 0.00% | -100.0% |
| Q4 2015 | $1,016,000 | +16.9% | 31,415 | +52.5% | 0.00% | 0.0% |
| Q3 2015 | $869,000 | – | 20,605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
| Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
| Grace Capital | 312,514 | $11,876,000 | 4.65% |
| NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
| Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
| Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
| Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
| EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
| ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
| Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |